Does OFATUMUMAB Cause Thrombocytopenia? 354 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 354 reports of Thrombocytopenia have been filed in association with OFATUMUMAB (ARZERRA). This represents 1.2% of all adverse event reports for OFATUMUMAB.
354
Reports of Thrombocytopenia with OFATUMUMAB
1.2%
of all OFATUMUMAB reports
13
Deaths
12
Hospitalizations
How Dangerous Is Thrombocytopenia From OFATUMUMAB?
Of the 354 reports, 13 (3.7%) resulted in death, 12 (3.4%) required hospitalization, and 3 (0.8%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for OFATUMUMAB.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which OFATUMUMAB Alternatives Have Lower Thrombocytopenia Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB